FIFTY-TWO-WEEK EFFICACY AND SAFETY OF VILDAGLIPTIN VS. GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN MONOTHERAPY

FERRANNINI, E., FONSECA, V., & ZINMAN, B.. (2009). FIFTY-TWO-WEEK EFFICACY AND SAFETY OF VILDAGLIPTIN VS. GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN MONOTHERAPY. DIABETES OBESITY AND METABOLISM, 11(4), 405-405. SID. https://sid.ir/paper/582426/en

FERRANNINI E., FONSECA V., ZINMAN B.. FIFTY-TWO-WEEK EFFICACY AND SAFETY OF VILDAGLIPTIN VS. GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN MONOTHERAPY. DIABETES OBESITY AND METABOLISM[Internet]. 2009;11(4):405-405. Available from: https://sid.ir/paper/582426/en

E. FERRANNINI, V. FONSECA, and B. ZINMAN, “FIFTY-TWO-WEEK EFFICACY AND SAFETY OF VILDAGLIPTIN VS. GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN MONOTHERAPY,” DIABETES OBESITY AND METABOLISM, vol. 11, no. 4, pp. 405–405, 2009, [Online]. Available: https://sid.ir/paper/582426/en